Beckman Coulter seeks authorization for $4 antigen test

antigen testing, Beckman Coulter, biopharma nl, coronavirus, COVID-19, Daily, Diagnostics, SYN, Top Story / December 18, 2020

Beckman Coulter said it would file for an emergency use authorization for a SARS-CoV-2 antigen test that costs only $4.